# FDA Inspection 1171015 - Walfer Corporation dba Wallace Pharmacy - May 26, 2022

Source: https://www.keypedia.com/records/fda_inspections/walfer-corporation-dba-wallace-pharmacy/4338b374-55cc-4d08-aae3-b7d5362dba29
Source feed: FDA_Inspections

> FDA Inspection 1171015 for Walfer Corporation dba Wallace Pharmacy on May 26, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171015
- Company Name: Walfer Corporation dba Wallace Pharmacy
- Inspection Date: 2022-05-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1120795 - 2020-03-16](https://www.keypedia.com/records/fda_inspections/walfer-corporation-dba-wallace-pharmacy/4ce44d3c-af03-4a82-8c2b-fbbcb183fbf3)

Company: https://www.keypedia.com/companies/walfer-corporation-dba-wallace-pharmacy/2bf8cf0b-3882-4575-bed4-f1c97b5cee6a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c